Invitae

Invitae Shares Outstanding

Delisted

The The number of shares of Invitae (NVTAQ) as of Oct 28, 2026 is 286.49 M. In the previous year, The number of shares was 286.49 M — a change of 0.00% (lower).

Shares Outstanding

286.49 M

YoY

0.00%

Last updated:

In 2023, Invitae had 286.49 M outstanding stocks, a 0.00% change from the 286.49 M stocks in the previous year.

The Invitae Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2019
286.49 M USD
Jan 1, 2020
286.49 M USD
Jan 1, 2021
286.49 M USD
Jan 1, 2022
286.49 M USD
Jan 1, 2023
286.49 M USD
Jan 1, 2024 (e)
275.60 USD
Jan 1, 2025 (e)
275.60 USD
Jan 1, 2026 (e)
275.60 USD
The Invitae Shares Outstanding history
YEARShares OutstandingYoY
est275.600.00%
est275.600.00%
est275.60-100.00%
286.49 M0.00%
286.49 M0.00%
286.49 M0.00%
286.49 M0.00%
286.49 M0.00%
286.49 M0.00%
286.49 M0.00%
286.49 M0.00%
286.49 M0.00%
286.49 M+1.93 B%
14.88+1,388.01%
1.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Invitae Number of shares

Invitae shares outstanding

The number of shares of Invitae was 275.6 M in 2025. This indicates how many shares Invitae is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
97.37 M Stocks
Jan 1, 2020
179.86 M Stocks
Jan 1, 2021
226.85 M Stocks
Jan 1, 2022
243.95 M Stocks
Jan 1, 2023
275.60 M Stocks
Jan 1, 2024 (e)
275.60 M Stocks
Jan 1, 2025 (e)
275.60 M Stocks
Jan 1, 2026 (e)
275.60 M Stocks

Invitae Stock analysis

What does Invitae do? Invitae Corp is a US-based company specialized in providing genetic tests for the diagnosis, treatment, and prevention of diseases. It was founded in 2010 and is headquartered in San Francisco, California. The company's goal is to lower the cost of genetic testing and increase accessibility for patients through automation and sample pooling methods. Invitae has received significant funding and has expanded its capital through multiple rounds of investments from venture capital firms, totaling nearly half a billion dollars. Its business model focuses on offering genetic tests to a wide range of patient groups, streamlining the testing processes through automation and software optimization. Invitae serves consumers directly, as well as medical professionals, hospitals, health centers, laboratories, and health insurance companies. The company aims to improve disease diagnosis and early detection while promoting long-term patient health. Invitae has broadened its capabilities through strategic acquisitions and partnerships, consolidating genetic data on a single platform. It offers a diverse portfolio of genetic tests for the diagnosis, treatment, and prevention of various diseases, including cancer predisposition, cardiovascular diseases, rare inherited diseases, neurological disorders, and medical genomics. The company also provides genetic counseling and family-oriented diagnosis services, along with an online platform facilitating interactive communication between doctors and patients, enabling the sharing and presentation of genetic information and test results. Invitae is an innovative company that has established itself as a market leader in genetic testing, offering a wide range of products and services facilitated by advanced technologies and data storage solutions. The recent acquisitions and partnerships have expanded Invitae's portfolio, improved its technology platform, and strengthened its position as a provider of high-quality healthcare services, enabling well-informed decision-making for patients and medical professionals. Invitae is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating Invitae's Shares Outstanding

Invitae's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Invitae’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Invitae’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Invitae’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Invitae stock

The number of shares of Invitae is 286.49 M in 2023.

The number of shares of Invitae changed from 286.49 M to 286.49 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares Invitae since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Invitae

All Key Metrics — Invitae